B-Cell Responses to Sars-Cov-2 mRNA Vaccines.
Pathog Immun
; 7(2): 93-119, 2022.
Article
in English
| MEDLINE | ID: covidwho-2265580
ABSTRACT
Most vaccines against viral pathogens protect through the acquisition of immunological memory from long-lived plasma cells that produce antibodies and memory B cells that can rapidly respond upon an encounter with the pathogen or its variants. The COVID-19 pandemic and rapid deployment of effective vaccines have provided an unprecedented opportunity to study the immune response to a new yet rapidly evolving pathogen. Here we review the scientific literature and our efforts to understand antibody and B-cell responses to SARS-CoV-2 vaccines, the effect of SARSCoV-2 infection on both primary and secondary immune responses, and how repeated exposures may impact outcomes.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Topics:
Vaccines
/
Variants
Language:
English
Journal:
Pathog Immun
Year:
2022
Document Type:
Article
Affiliation country:
Pai.v7i2.550
Similar
MEDLINE
...
LILACS
LIS